These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 6585139)

  • 21. High frequency of de novo deletions in Mexican Duchenne and Becker muscular dystrophy patients. Implications for genetic counseling.
    Alcántara MA; Villarreal MT; Del Castillo V; Gutiérrez G; Saldaña Y; Maulen I; Lee R; Macías M; Orozco L
    Clin Genet; 1999 May; 55(5):376-80. PubMed ID: 10422811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benign muscular dystrophy: risk calculation in families with consanguinity.
    Wolff G; Müller CR; Grimm T
    J Med Genet; 1989 May; 26(5):299-304. PubMed ID: 2732990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Screening for elevated creatine kinase activities for the early diagnosis of Duchenne muscular dystrophy].
    Beckmann R; Scheuerbrandt G
    Fortschr Med; 1979 Oct; 97(39):1733-6. PubMed ID: 511067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular diagnosis of Duchenne and Becker muscular dystrophies. Current data].
    Junien C; Boué J; Duros C; Coulon M; Cohen P; Dehaupas I; Gallano P; Léotard B; Nicolas H; Boué A
    Ann Genet; 1987; 30(1):5-16. PubMed ID: 3498430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carrier diagnosis of Duchenne muscular dystrophy using restriction fragment length polymorphisms.
    Hejtmancik JF; Harris SG; Tsao CC; Ward PA; Caskey CT
    Neurology; 1986 Dec; 36(12):1553-62. PubMed ID: 2878392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The use of discriminant analysis of serum creatine kinase levels for detection of heterozygote carriers of Duchenne muscular dystrophy].
    Krasil'nikov VV; Labeznik TA; Shilov LA
    Genetika; 1987 Jan; 23(1):176-9. PubMed ID: 3817468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic counseling in Duchenne muscular dystrophy.
    Bradley WG; Kelemen J
    Muscle Nerve; 1979; 2(5):325-8. PubMed ID: 492208
    [No Abstract]   [Full Text] [Related]  

  • 29. Carrier detection and genetic counselling in Duchenne dystrophy.
    Dubowitz V
    Dev Med Child Neurol; 1975 Jun; 17(3):352-6. PubMed ID: 1107098
    [No Abstract]   [Full Text] [Related]  

  • 30. Multipoint linkage mapping of the Emery-Dreifuss muscular dystrophy gene.
    Kress W; Müller E; Kausch K; Kullmann F; Mostacciuolo ML; Rietschel M; Rotthauwe HW; Schmalenberger B; Siciliano G; Voit T
    Neuromuscul Disord; 1992; 2(2):111-5. PubMed ID: 1422197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The manifesting carrier in Duchenne muscular dystrophy.
    Moser H; Emery AE
    Clin Genet; 1974; 5(4):271-84. PubMed ID: 4854942
    [No Abstract]   [Full Text] [Related]  

  • 32. [The use of Bayes theorum in genetic counseling in cases of Duchenne muscular dystrophy].
    Dodinval P
    J Genet Hum; 1979 Jun; 27(2):131-43. PubMed ID: 541678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linkage studies in Duchenne and Becker muscular dystrophies.
    Walker A; Hart K; Cole C; Hodgson S; Johnson L; Dubowitz V; Bobrow M
    J Med Genet; 1986 Dec; 23(6):538-47. PubMed ID: 2879925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic linkage study between the loci for Duchenne and Becker muscular dystrophy and nine X-chromosomal DNA markers.
    Wilichowski E; Krawczak M; Seemanova E; Hanefeld F; Schmidtke J
    Hum Genet; 1987 Jan; 75(1):32-40. PubMed ID: 3026946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lactate dehydrogenase isoenzyme in detecting carriers of Duchenne muscular dystrophy.
    Roses AD; Roses MJ; Nicholson GA; Roe CR
    Neurology; 1977 May; 27(5):414-21. PubMed ID: 558544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Creatine phosphokinase activity in serum of carriers of progressive muscular dystrophy of Duchenne type].
    Barthelmai W; Dikbas G; Wüllner S
    Humangenetik; 1969 Oct; 8(2):115-33. PubMed ID: 5365581
    [No Abstract]   [Full Text] [Related]  

  • 37. Linkage between the loci for benign (Becker-type) X-borne muscular dystrophy and deutan colour blindness.
    Skinner R; Smith C; Emery AE
    J Med Genet; 1974 Dec; 11(4):317-20. PubMed ID: 4548442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tests of serum creatine phosphokinase activity in patients with progressive muscular dystrophy and their relatives for the detection of genetic carriers].
    László A; Salgó L
    Orv Hetil; 1981 Jun; 122(24):1453-6. PubMed ID: 7290660
    [No Abstract]   [Full Text] [Related]  

  • 39. Italian experience regarding the prevention of Duchenne and Becker muscular dystrophies.
    Romeo G; Devoto M; Archidiacono N; Ferlini A; Roncuzzi L; Melis MA; Paderi E; Ferrari M; Tedeschi S; Galluzzi G
    Eur J Pediatr; 1988 May; 147(4):412-5. PubMed ID: 3165066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linkage localization of facioscapulohumeral muscular dystrophy (FSHD) in 4q35.
    Mathews KD; Mills KA; Bosch EP; Ionasescu VV; Wiles KR; Buetow KH; Murray JC
    Am J Hum Genet; 1992 Aug; 51(2):428-31. PubMed ID: 1642242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.